Role of BRCA gene dysfunction in breast and ovarian cancer predisposition
AUTOR(ES)
Scully, Ralph
FONTE
BioMed Central
RESUMO
Tumor suppressor genes that perform apparently generic cellular functions nonetheless cause tissue-specific syndromes in the human population when they are mutated in the germline. The two major hereditary breast/ovarian cancer predisposition genes, BRCA1 and BRCA2, appear to participate in a common pathway that is involved in the control of homologous recombination and in the maintenance of genomic integrity. How might such functions translate into the specific suppression of cancers of the breast and ovarian epithelia? Recent advances in the study of BRCA1 and BRCA2, discussed herein, have provided new opportunities to address this question.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=138653Documentos Relacionados
- The role of the breast cancer susceptibility gene 1 (BRCA1) in sporadic epithelial ovarian cancer
- Contribution of BRCA1 and BRCA2 Mutations to Breast and Ovarian Cancer in Pakistan
- Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil
- BRCA1 and BRCA2 mutation analysis in 86 early onset breast/ovarian cancer patients.
- BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome